Skip to content

West Pharmaceutical Services

US · WST #752 by market cap Listed 1970
390.30 -6.39 -1.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 399.50 +0.71%
After-hours 390.30 0.00%
Overnight 399.50 +0.71%
417.80311.77390.302026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on WST?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +31.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 2.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 43.8x Better than 11%
Forward P/E 38.8x Better than 11%
Price / Sales 8.0x Better than 13%
P/E vs own 5-yr range 55th pctl Better than 55%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 2.1% Better than 35%
Net income CAGR (3Y) -5.5% Better than 32%
Free cash flow CAGR (3Y) 2.2% Better than 41%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 35.9% Better than 42%
Operating margin 20.7% Better than 78%
Net margin 16.1% Better than 73%
Return on equity 16.9% Better than 72%
Return on invested capital 14.8% Better than 82%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 10.6% Better than 90%
6-month return 23.5% Better than 86%
12-month return (ex latest month) 45.0% Better than 81%
Distance below 52-week high 10.9% Better than 81%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.0x Better than 73%
Debt to assets 7.5% Better than 74%
Interest coverage 1,202.8x Better than 99%
Free cash flow / net income 95.0% Better than 35%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 22.5% Better than 37%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.27%
1M +0.45%
3M +10.40%
6M +27.92%
YTD +42.27%
1Y +51.86%
3Y +12.79%
5Y -11.80%

Key statistics

Price & volume

Prev close
396.69
Open
387.71
Day range
387.71 - 400.90
Avg price
391.89
Volume
623.50K
Turnover
244.34M
Amplitude
3.33%
52-week range
223.37 - 437.99

Valuation

P/E
57.48
P/E (TTM)
43.80
P/B
9.16
EPS
6.79
Net profit
473.00M
Net assets
2.97B

Share structure

Market cap
27.19B
Float cap
26.99B
Shares out
69.66M
Float shares
69.15M

Dividend & listing

Dividend (TTM)
0.88
Listing date
1970-01-01
52-week range 78% of range
223.37 437.99

10.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-24.08M net over the window

Short interest

Shares short
1.81M
As of
2026-10-30

Frequently asked questions

What is the current stock price of West Pharmaceutical Services (WST)?

West Pharmaceutical Services last traded at 390.30. This page shows a periodic quote snapshot. Check the displayed quote time.

What is West Pharmaceutical Services's market cap?

About 27.19B.

What is the P/E ratio of West Pharmaceutical Services?

The trailing twelve-month P/E is 43.80, above its own 5-year average of 42.25 — in the middle of its historical range (54.74% percentile). See the Valuation tab for the full history.

Does West Pharmaceutical Services pay a dividend?

Yes. The trailing dividend yield is 0.23%. The 2025 payout was up 4.9% from 2024. See the Dividends tab for the full payment history.

Is West Pharmaceutical Services a buy according to analysts?

The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 478.17, which implies 22.5% upside from the current price. This is not investment advice.

What is West Pharmaceutical Services's StockVane Quant Rating?

The StockVane Momentum strategy currently rates West Pharmaceutical Services a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

West Pharmaceutical Services discussion 0 comments

Add a comment